Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Intracranial Aneurysm Market, by End-use
1.4.2 Europe Intracranial Aneurysm Market, by Type
1.4.3 Europe Intracranial Aneurysm Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Intracranial Aneurysm Market by End-use
4.1 Europe Hospitals Market by Country
4.2 Europe Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Intracranial Aneurysm Market by Type
5.1 Europe Endovascular Coiling Market by Country
5.2 Europe Flow Diverters Market by Country
5.3 Europe Surgical Clipping Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Intracranial Aneurysm Market by Country
6.1 Germany Intracranial Aneurysm Market
6.1.1 Germany Intracranial Aneurysm Market by End-use
6.1.2 Germany Intracranial Aneurysm Market by Type
6.2 UK Intracranial Aneurysm Market
6.2.1 UK Intracranial Aneurysm Market by End-use
6.2.2 UK Intracranial Aneurysm Market by Type
6.3 France Intracranial Aneurysm Market
6.3.1 France Intracranial Aneurysm Market by End-use
6.3.2 France Intracranial Aneurysm Market by Type
6.4 Russia Intracranial Aneurysm Market
6.4.1 Russia Intracranial Aneurysm Market by End-use
6.4.2 Russia Intracranial Aneurysm Market by Type
6.5 Spain Intracranial Aneurysm Market
6.5.1 Spain Intracranial Aneurysm Market by End-use
6.5.2 Spain Intracranial Aneurysm Market by Type
6.6 Italy Intracranial Aneurysm Market
6.6.1 Italy Intracranial Aneurysm Market by End-use
6.6.2 Italy Intracranial Aneurysm Market by Type
6.7 Rest of Europe Intracranial Aneurysm Market
6.7.1 Rest of Europe Intracranial Aneurysm Market by End-use
6.7.2 Rest of Europe Intracranial Aneurysm Market by Type
Chapter 7. Company Profiles
7.1 MicroVention, Inc. (Terumo Corporation)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and Approvals:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 MicroPort Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental & Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Integra LifeSciences Holdings Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Delta Surgical
7.8.1 Company Overview
7.9 Penumbra, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
Unique Offerings 